Novo Nordisk A/S (NVO)
37.52
+0.08
(+0.21%)
USD |
NYSE |
Apr 10, 16:00
37.02
-0.50
(-1.33%)
Pre-Market: 07:31
Novo Nordisk Accounts Payable (Quarterly) : 3.107B for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Evaxion AS | 2.186M |
| Ascendis Pharma A/S | 106.47M |
| Viking Therapeutics, Inc. | 53.25M |
| DBV Technologies SA | 40.94M |
| Cellectis SA | 17.28M |